Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

14.54
+0.19001.32%
Post-market: 14.600.0586+0.40%19:58 EDT
Volume:2.54M
Turnover:37.37M
Market Cap:2.01B
PE:-4.03
High:15.01
Open:14.20
Low:14.11
Close:14.35
52wk High:15.87
52wk Low:4.82
Shares:138.00M
Float Shares:107.00M
Volume Ratio:0.74
T/O Rate:2.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6118
EPS(LYR):-3.0800
ROE:-319.07%
ROA:-29.08%
PB:23.74
PE(LYR):-4.72

Loading ...

Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs

Reuters
·
11 hours ago

FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace

Reuters
·
14 hours ago

Strata Mental Health Solutions awarded training grant by Compass Pathways

TIPRANKS
·
Sep 12

Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval Comp360 Provider Training

THOMSON REUTERS
·
Sep 10

Compass Pathways Management Attends Investor Conference Fireside Chats in New York Week of Sept. 14

Reuters
·
Sep 10

U.S. Stocks on the MOVE-Apple, Omnicom, Jersey Mike's Subs

Reuters
·
Sep 10

U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software

Reuters
·
Sep 09

Compass Pathways Rises After One-Year Data for Psychedelic-Based Depression Drug

Reuters
·
Sep 09

Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 Comp005 Trial Demonstrates Additional Benefit from Another Comp360 Dose in Part C Extending Durability Out to 1 Year

THOMSON REUTERS
·
Sep 09

Compass Pathways - Rolling Nda Submission Underway; Final Submission on Track for Q4

THOMSON REUTERS
·
Sep 09

Compass Pathways - Continue to Expect Commercial Launch in H1 2027

THOMSON REUTERS
·
Sep 09

Compass Pathways - Comp360 Safety Profile in Part C Consistent with Prior Parts; no New Safety Findings

THOMSON REUTERS
·
Sep 09

Compass Pathways - 25 Mg Arm Shows Average 13-Point Madrs Reduction at Week 52 with Durability to 1 Year

THOMSON REUTERS
·
Sep 09

Compass Pathways Grants Inducement Equity Awards Covering 414,100 Shares to New Hires

Reuters
·
Sep 04

Compass Pathways to Join Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 01

Unusually active option classes on open August 26th

TIPRANKS
·
Aug 26

COMPASS Pathways (CMPS) Nears FDA Filing for COMP360 Following a Valuation Question

Simply Wall St.
·
Aug 26

Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path

TIPRANKS
·
Aug 21

How COMPASS Pathways’ VA Psilocybin Trial (CMPS) Has Reframed Its Veteran Mental Health Ambitions

Simply Wall St.
·
Aug 20

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

TIPRANKS
·
Aug 13